U.S. President-elect Donald Trump is expected to nominate Johns Hopkins surgeon Martin Makary to head the FDA. Makary, known for his views on natural immunity and opposition to COVID vaccine mandates, could bring unconventional changes to the influential agency responsible for overseeing drugs, food safety, and medical devices.
Jay Bhattacharya is reportedly President-elect Donald Trump's top choice for NIH director. Bhattacharya impressed Trump's cabinet pick for HHS with his innovative ideas for NIH overhaul, focusing on funding research. His selection aligns with Trump's earlier choice of Robert F. Kennedy Jr. to lead HHS.
President-elect Donald Trump has praised the polio vaccine as the “greatest thing,” but a lawyer affiliated with Trump’s pick to lead the country’s top health agency has petitioned the US Food and Drug Administration to revoke approval of the vaccine used in the United States.
The FDA is seeking to rehire some of the scientists recently fired amid pressure from Elon Musk, who has ties to Neuralink. The agency aims to bring back around 300 personnel after Trump's abrupt dismissals. The rehirings follow ongoing Neuralink trials, which the agency approved despite past safety concerns.
The Trump administration's staff reductions and cuts to research funding could potentially cause young scientists to leave the U.S. in search of more stable opportunities abroad.
The Trump administration proposes significant budget cuts affecting health and research sectors. Texas reports 683 measles cases amid nationwide outbreaks. Medical device demand boosts Stryker's earnings. The FDA reviews weight-loss drugs, while Neuralink's device for speech restoration gains breakthrough status. Thailand faces its first anthrax death in decades.
The US FDA approved Moderna's next-generation COVID-19 vaccine, mNexspike, for adults 65+ and at-risk individuals aged 12-64. This low-dose option enhances immunity with fewer restrictions compared to previous vaccines. The decision followed a study affirming its safety and effectiveness, despite financial hurdles from the Trump administration.
If there’s anything the Trump administration has gotten unequivocally right (besides inadvertently helping Mark Carney become prime minister of Canada), it’s this: Modern science, for all its remarkable capabilities, still remains far too dependent on one of …
A drug called lenacapavir, administered in two injections a year, offers protection from HIV comparable to daily pills. One looming question: Will it be affordable for lower resource countries?
Francis Collins has overseen some of the most revolutionary science of the last few decades. He led the Human Genome Project that sequenced the entire human genome by 2003, and then in 2009, he became director of the National Institutes of Health, where he se…
Jessica Chaikof says research into gene therapies could someday save her eyesight. But she worries cuts to federal research funding could mean that therapy won't be ready in time.
A presentation slated to be shared at this week’s meeting of vaccine advisers to the US Centers for Disease Control and Prevention claimed that a study in...
President Trump's pick for the director of Centers for Disease Control and Prevention, Dr. Susan Monarez, is set to face questions about her vision for the agency.
ABC Newsby Sarah Beth Hensley, Will McDuffie, Cheyenne Haslett
This story appeared in The Logoff, a daily newsletter that helps you stay informed about the Trump administration without letting political news take over your life. Subscribe here. Welcome to The Logoff: An influential panel that makes vaccine recommendation…
NASA and the National Science Foundation cancelled their major events at a major astronomy conference this summer. Scientists who attended were left disappointed.
Merck & Co., Inc. (NYSE:MRK) is one of the 12 stocks that will make you rich in 10 years. On June 23, the company shared encouraging results from its Phase 3...
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) ranks among the best fundamental stocks to buy according to hedge funds. With a price target of $550, H.C. ...
Besides nicotine replacement therapies, the FDA has only approved two smoking cessation drugs without nicotine. This may change soon if cytisinicline gets approved.
Forbesby Joshua P. Cohen, Senior Contributor,
Joshua P. Cohen, Senior Contributor
https://www.forbes.com/sites/joshuacohen/
UroGen Pharma Ltd. (NASDAQ:URGN) is one of the best hot stocks to buy according to Wall Street analysts. In mid-June, UroGen Pharma announced that the US FDA...
ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) is one of the best hot stocks to buy according to Wall Street analysts. On July 3, ImmunoPrecise Antibodies...
The symptoms can include nerve pain, emotional numbness and sexual dysfunction and can last for years after stopping the drugs. Patients are pushing for recognition and more research.
If successful, the access model for sickle cell disease gene therapies could serve as a blueprint for other such treatments that have faced major patient access barriers.
Forbesby Joshua P. Cohen, Senior Contributor,
Joshua P. Cohen, Senior Contributor
https://www.forbes.com/sites/joshuacohen/
The Trump administration cancelled about $500 million for research into mRNA vaccines. The move slows progress in using the technology to prevent a future pandemic or treat disease, experts say.
HHS is slashing hundreds of millions in funding for mRNA vaccines and infectious disease treatments, but leaving the door open to mRNA therapies for cancer and genetic conditions.
Remarkable new treatments can free millions of kids and adults from the deadly threat of peanut allergy, tackling one of our fastest-growing medical problems
A report that health secretary Robert F. Kennedy, Jr. has promised will come out this month will look at the causes of autism. Many worry it will have claims unsupported by science.
Readers respond to Rachel Aviv’s report on a schizophrenia patient who turned out to have an autoimmune disease, Zach Helfand’s Talk of the Town story about Youman Wilder, and Hua Hsu’s article on A.I. and education.
New dietary guidelines are coming soon. Health secretary Robert F. Kennedy Jr. has promised the days of skim milk and other low fat dairy products are over. Is there a case for more fat in dairy?
Scientists will not find a simple answer to how autism arises, despite Robert F. Kennedy, Jr.’s promise to announce its causes sometime this month. Here’s what makes the condition so staggeringly complex
Researchers tested 12 “magic mushroom” edibles. None contained psilocybin, but most contained undisclosed ingredients, including synthetic drugs whose safety hasn’t been tested in humans
Though brain chips are all over TV and the news now with Neuralink, scientists like those at Caltech have been working on the technology for decades. And some question Musk’s approach
This year’s WIRED Health summit in Boston featured Moderna CEO Stéphane Bancel, CNN chief medical correspondent Sanjay Gupta, and a day’s worth of insights and provocative conversations.
Science writer Mary Roach chronicles both the history and the latest science of body part replacement in her new book. She also answers the question: Is it kosher to receive an organ donation from a pig?
In this article, we will be taking a look at the Top 10 AI-Powered Biotech Stocks to Buy Now. Pfizer Inc. is one of them. Pfizer Inc. (NYSE:PFE), a global...
Major medical groups stated acetaminophen is safe for pregnant women to take and that no studies have found a direct cause and effect between use in pregnancy and autism.
Scientific evidence is lacking to support the US government’s decisions to caution against using a common painkiller in pregnancy and fast-track the approval of an experimental medication for autism
Back in April, RFK Jr. committed publicly to firmly knowing the cause of autism by September of this year. In May, Donald Trump himself weighed in with the already baked conclusion that autism doesn’t “occur naturally” and therefore must have some environment…
An optimistic take on the state of the longevity field provides hope for treating a range of ageing-related diseases — but feels at odds with the current shape of US research.
My cancer is back. This is disappointing but not unexpected; of the 2/3 of people who survive their first bout with ovarian cancer, 80% usually have it recur at some point. For me it was sooner than expected, and disheartening because, even if I beat it back …
Kennedy’s doubling down on disputed links isn't a one-off. He has often done this regarding exposure to substances like acetaminophen that he thinks are linked to autism.
Forbesby Joshua P. Cohen, Senior Contributor,
Joshua P. Cohen, Senior Contributor
https://www.forbes.com/sites/joshuacohen/
Despite the widespread use of medication during pregnancy, a lack of clinical research leaves patients and doctors navigating treatment with dangerously few data.
Scientific Americanby Rachel Feltman, Tanya Lewis, Fonda Mwangi, Alex Sugiura
The new Trump administration multiyear funding policy for NIH grants has dropped National Cancer Institute grant funding rates from one in 10 applicants to one in 25.
Forbesby Bruce Y. Lee, Senior Contributor,
Bruce Y. Lee, Senior Contributor
https://www.forbes.com/sites/brucelee/
In these financially straitened times, funders must recognize that great discoveries often arise from work that was looking for something completely different.
President Donald Trump's embrace of an old generic drug called leucovorin for use against a rare disorder that causes autism-like symptoms has triggered a...
New research from Australia overturns the old idea that exercise “uses up” heartbeats. It shows that fitter people actually use fewer total heartbeats each day thanks to their lower resting heart rates, even when accounting for workouts. Athletes’ hearts beat…
At 69 years old, Debby Orcutt was diagnosed last year with pancreatic cancer, a condition so dire that her doctor refused to tell her how long she had to...
The Washington Postby Daniel Gilbert, (c) 2025 , The Washington Post
Vaccines based on mRNA can be tailored to target a cancer patient’s unique tumor mutations. But crumbling support for cancer and mRNA vaccine research has endangered this promising therapy
A Centers for Disease Control and Prevention webpage that previously stated "Vaccines do not cause autism" has been changed to cast doubt on the scientific research that supports the finding.
Bristol-Myers Squibb Company (NYSE:BMY) is included among the 15 Best Boring Dividend Stocks to Buy. Bayer reported positive Phase 3 results for its FXIa ...
Amid NIH funding delays, reversals and uncertainty, a scientist at Harvard who studies breast cancer has lost one-third of her lab employees and wonders if she can continue her research experiments.
Akebia Therapeutics Inc. (NASDAQ:AKBA) is one of the cheap penny stocks to invest in. On December 1, Akebia Therapeutics announced the official establishment...
After the leucovorin got public attention as a potential autism treatment, families rushed to get it. Many doctors are torn about prescribing an unproven drug but don't want to lose patients' trust.
The COVID pandemic ushered mRNA vaccines into the spotlight, and the technology has even greater potential. Here’s what to know about the way that they work, their safety, and more
The U.S. Food and Drug Administration is seeking to accelerate the review process for three companies that are studying psilocybin and an MDMA-like drug as treatments for depression and PTSD
Families with rare gene mutations that cause Alzheimer's in middle age are giving scientists a unique window on the disease, and a quick way to test potential treatments.
ABC News’ Linsey Davis explains the numbers behind a new pancreatic cancer treatment that almost doubles the prognosis for patients, and speaks to Dr. Brandon Huffman, whose team is behind the drug.
Alvotech (NASDAQ:ALVO) is one of the most promising penny stocks according to Wall Street analysts. On May 11, Alvotech announced the completion of a routine...
Proteins that ‘buffer’ the effects of mutations could help to treat diseases such as cancers. Plus, goats can follow human voices and the battle over a key ocean observatory project in the United States.
BeOne Medicines Ltd. (NASDAQ:ONC) is one of the high-growth large-cap stocks to invest in. On June 11, BeOne Medicines Ltd. (NASDAQ:ONC) presented updated Ph...
A very connected 79-year-old chonker reportedly got access to Eli Lilly's experimental obesity drug retatrutide, and the White House will not directly say whether that man is McDonald's slurping Grandpa Pudding Brains.
Raw Story summarizes STAT's report that …
Eli Lilly and Company (NYSE:LLY) is one of the top trending US stocks to buy now. Eli Lilly and Company (NYSE:LLY) and BioArctic AB announced on June 22 thei...
For the first time, surgeons at UC San Diego have operated using humanoid robots, removing gallbladders in two procedures on pigs, a key step before any human trials.